About this research peptide
Semaglutide is a long-acting GLP-1 receptor agonist that has been studied in published literature for its role in glucose homeostasis, insulin sensitivity, and weight-regulation pathways. Researchers investigating PMOS/PCOS-related insulin resistance and post-menopausal metabolic shifts have included Semaglutide in their reference compound libraries.
Researchers exploring conditions that disproportionately affect women — including autoimmune-driven inflammation, perimenopausal symptom mapping, hormonal-metabolic dysregulation, and post-surgical recovery in women’s-health procedures — have included this compound in their reference libraries.
This product is supplied as a lyophilized powder of ≥99% purity, with a lot-specific Certificate of Analysis available through the link in the Specifications tab.
Cited research
Cited research will be published on this product page as new literature is indexed. Citations are provided for research context only — inclusion does not imply any health claim or endorsement of personal use.








